NCT06887387
Wearable Devices for Patient Monitoring in Long QT Syndrome
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Sep 4, 2026 to Sep 4, 2027
- Eligibility criteria expanded, about 7 words
- Minor Primary completion date: Apr 30, 2026 to Sep 4, 2026v3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Primary completion date: Apr 3, 2026 to Apr 30, 2026
- Start date changed from estimate of Apr 4, 2025 to Apr 1, 2025
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
1. Determine the accuracy of repeated QT interval measurements using Fitbit-derived ECGs in patients with Long QT syndrome compared with the current standard (12-lead ECG and ambulatory monitors)
Timeframe: From enrollment to 3 months
2. Establish intra-patient QT variability from weekly Fitbit-ECGs and frequency of measurements over 500ms.
Timeframe: From enrollment to 3 months
Secondary (2)
1. Establish the utility of wearable devices for determining symptom aetiology in LQTS.
2. Develop pipelines for the analysis of ECG data collected remotely including use of in-house QT automated algorithms for future machine learning applications.
Arms and interventions
Devices: Wearable device
Sites
1 site in 1 country
- Barts and London Hospital NHS TrustLondon, United Kingdom